NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
HHS-NIH11
POSTED: 11/21/2024
UPDATED: 11/21/2024
DUE: 11/17/2026
This notice of funding opportunity (NOFO) invites applications for investigator-initiated clinical trials of complementary and integrative health approaches with physical and/or psychological therapeu...
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/20/2024
UPDATED: 11/20/2024
DUE: 11/19/2026
This NOFO encourages applications for multi-site exploratory and confirmatory clinical trials focused on promising interventions; biomarker or outcome measure validation studies that are immediately p...
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
$300,000
HHS-NIH11
POSTED: 11/20/2024
UPDATED: 08/12/2025
DUE: 11/18/2027
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, ...
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/20/2024
UPDATED: 11/20/2024
DUE: 10/14/2027
The purpose of the NCI Pathway to Independence Award (K99/R00) program is to facilitate a timely transition of talented postdoctoral researchers with a research and/or clinical doctorate degree from m...
NHLBI Program Project Applications (P01 Clinical Trials Optional)
HHS-NIH11
POSTED: 11/20/2023
UPDATED: 11/20/2023
DUE: 09/25/2026
The National Heart, Lung, and Blood Institute (NHLBI) Program Project Grant (P01) supports research related to fundamental processes and diseases of the heart, blood and lymphatic vessels, lungs, and ...
NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/18/2024
UPDATED: 11/19/2024
DUE: 02/26/2027
The Small Business Innovation Research (SBIR) Program is an important National Institutes of Health (NIH) funding mechanism used to develop innovative solutions that address public health challenges. ...
NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/18/2024
UPDATED: 11/19/2024
DUE: 02/26/2027
The Small Business Innovation Research (SBIR) Program is an important funding mechanism that the National Institutes of Health (NIH) uses to develop innovative solutions that address public health cha...
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/18/2024
UPDATED: 11/18/2024
DUE: 11/16/2025
The NIH Common Fund has established the Gabriella Miller Kids First Pediatric Research Program (Kids First) to develop a pediatric research data resource populated by genome sequence and phenotypic da...
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
$100,000
HHS-NIH11
POSTED: 11/18/2024
UPDATED: 11/18/2024
DUE: 03/16/2026
This Small Research Grant (R03) will support meritorious projects to provide needed scientific insight to improve the prevention, diagnosis, treatment, and/or care for individuals with Alzheimer's dis...
Enhancing Reuse of NHGRI Data Assets (R03 Clinical Trial Not Allowed)
$125,000
HHS-NIH11
POSTED: 11/18/2024
UPDATED: 11/18/2024
DUE: 02/15/2026
To support secondary analysis of AnVIL datasets and increase utilization of the AnVIL platform for small research projects by eliminating the cost barriers new users face. Through this additional anal...